October 16-18, 2022
HEALTH AND SAFETY DURING THE CONFERENCE
For the health and safety of attendees, staff, and the local community, at this time, all attendees should be fully vaccinated and are required to wear a mask at all times while in the meeting room and other public spaces. If you feel sick prior to traveling, do not come. We plan to set up conference meeting rooms with adequate space for social distancing, sanitizing surfaces regularly, along with other precautions will be taken to ensure your safety throughout the conference. We will continue to monitor the Centers for Disease Control and Prevention guidelines as well as San Diego and California ordinances.
2022 RWHAP CLINICAL CONFERENCE Description
The 2022 Ryan White HIV/AIDS Program (RWHAP) CLINICAL CONFERENCE will be held in-person in San Diego, California, from Sunday, October 16, to Tuesday, October 18, as long as it is safe and practical to meet in-person. The RWHAP CLINICAL CONFERENCE will provide state-of-the-art updates on research, care, and treatment issues in the medical management of HIV infection for experienced HIV clinical decision makers.
The 2022 RWHAP CLINICAL CONFERENCE is planned with and supported by the HIV/AIDS Bureau, Health Resources and Services Administration of the US Department of Health and Human Services (HRSA) and is sponsored and organized by the International Antiviral Society-USA (IAS-USA). This conference is coordinated through the RWHAP AIDS Education and Training Centers (AETC) clinician training network. A mix of lectures, case-based interactive presentations, and small-group workshop breakout sessions will be held during the 3 days of the 2022 RWHAP CLINICAL CONFERENCE.
Who Should Attend
Attendance is limited to 400 HIV physicians, nurse practitioners, and physician assistants in Ryan White HIV/AIDS Program (RWHAP)-funded clinics and programs (specifically for in part A, B, C, and D), who functions as medical director of their clinic. As we are not sure what the status of the COVID-19 pandemic will be in October, we are planning for distanced seating in the main meeting space. This will limit the number of attendees we can accommodate to ensure the health and safety of our attendees. The first 300 registrants will have access to seating in the main meeting room. The next 100 registrants will be in the overflow seating outside the main meeting room, but will still have access to breakout sessions and networking opportunities. At this point, given the limited attendance, in most cases there is a limit of 2 participants from each clinic, which can include 1 Registered Nurse and 1 Pharmacist.
The 2022 RWHAP CLINICAL CONFERENCE will offer limited number of registrations for RNs and PharmDs who are the primary clinical decision makers/medical directors in their RWHAP-funded clinics or programs.
There is no registration fee to attend.
The educational objectives for the 2022 RWHAP CLINICAL CONFERENCE are designed and developed based on the identified needs and knowledge gaps of the attendees.
On completion of the 2022 RWHAP CLINICAL CONFERENCE, participants will be able to:
- Describe the new aspects to the Ryan White HIV/AIDS Program
- Identify situations in which the choice of antiretroviral regimen should consider particular clinical circumstances, such as comorbid conditions, coinfections, pregnancy, and issues in older patients
- Describe the most current data on currently available and investigational new antiretroviral drugs, formulations, and strategies
- Initiate and monitor HIV prevention intervention strategies, including the use of long-acting injectable preexposure prophylaxis (PrEP), in individuals at risk for HIV infection
- Describe the current epidemiology, clinical presentations, and management of the most common sexually transmitted infections (STIs) in adults with HIV infection and in special populations such as adolescents
- Describe the current understanding of COVID-19 in people with HIV
- Detect and address practitioner and staff burnout
- Describe the current best practices of postnatal HIV care and prevention, including issues around breastfeeding
- Describe the risk factors and screening recommendations for non-AIDS cancers in people with HIV
- Diagnose and manage opportunistic infections in people with HIV
- Implement key primary care practices
- Describe the implications of mRNA vaccines for an HIV vaccine
- Detect and manage opioid use disorder in people with HIV
- Manage hepatitis B virus coinfection, including drug interactions and screening for hepatocellular carcinoma
- Provide gender-affirming care to people with HIV
- Address health disparities in disparate populations
- Describe the current status of the Ending the HIV Epidemic initiative
IAS-USA Accreditation Statement
The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The IAS–USA designates this live activity for a maximum of 15.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Points
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 15.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
American Academy of Family Physicians Credits
The AAFP has reviewed The 2022 Ryan White HIV/AIDS Program CLINICAL CONFERENCE and deemed it acceptable for up to 15.25 Live AAFP Prescribed credits. Term of Approval is from 10/16/2022 to 10/18/2022. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Educational Review Systems is an approved approver of continuing nursing education by the Alabama State Nursing Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Provider # 5-115. This program is approved for 15.75 hours of continuing nursing education.
Educational Review Systems is also approved for nursing continuing education by the state of California, the state of Florida and the District of Columbia.
This program is approved for 15.75 hours of pharmacotherapy credit.
Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program is approved for 15.75 hours (1.575 CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.
UAN # 0761-9999-21-304-L02-P
This conference is funded by the Health Resources and Services Administration (HRSA) of the US Department of Health and Human Services (HHS) under grant number U1OHA28686.
The networking reception is supported in kind by the IAS–USA.
Daily coffee is provided in kind by the Wyndham San Diego Bayside.